Three Pharma Companies, Walmart Hit with Class Action Over Sale of Allegedly NDEA-Contaminated Irbesartan
December 5, 2018 A class action lawsuit has been filed against four companies a consumer claims respectively made, distributed and sold carcinogen-contaminated Irbesartan.